TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
SLP

Simulations Plus Inc

Healthcare · Health Information Services

18.50$ +0.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Simulations Plus Inc (SLP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 153 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SLP
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
28 29 29 30 39 40 41 43 44 42 43 46 46 48 49 62 170 170 176 179 182 181 185 186 191 190 173 179 193 186 194 193 208 197 201 134 132 138 146 153
13 14 14 15 13 14 15 17 18 17 19 21 21 23 25 22 129 131 136 139 139 140 144 145 147 149 131 137 130 130 128 136 39 40 47 52 52 58 68 75
8.0 8.8 7.4 8.2 6.2 7.0 6.9 7.2 9.4 9.4 9.9 10 11 13 12 7.4 49 28 42 59 37 42 60 42 52 49 39 55 58 40 37 109 10 6.2 11 27 31 30 26 35
8.0 8.8 7.4 8.2 6.2 7.0 6.9 7.2 9.4 9.4 9.9 10 11 13 12 7.4 116 119 118 120 124 124 125 122 128 132 115 122 115 114 109 119 20 18 21 28 – 36 42 50
3.7 4.5 5.9 6.1 5.5 6.6 7.8 9.7 7.5 7.5 8.5 10 8.3 9.8 11 14 11 10 15 17 13 13 15 19 14 12 11 10 10 10 16 14 9.1 13 16 15 9.7 12 18 17
0.8 0.0 0.4 0.2 0.5 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.8 0.1 0.5 0.4 1.0 0.6 1.3 0.5 1.0 0.6 0.4 0.0 0.0 1.0 0.4 – 0.8 0.0 0.0 – 5.9 – – – – – – –
0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.6 0.9 2.7 3.1 2.3 0.6 2.1 2.1 0.7 0.8 0.7 – – – – – – – – – – – –
4.8 4.8 4.8 4.8 10 10 10 10 10 10 10 10 10 10 10 13 13 13 13 13 13 13 13 13 13 13 13 13 19 19 19 19 96 96 96 43 44 44 44 44
10 9.8 9.7 9.5 15 15 15 15 15 14 14 14 13 13 13 25 25 25 25 25 25 25 26 26 26 26 26 27 33 33 33 33 59 58 56 30 29 29 11 16
5.3 5.1 4.9 4.3 13 13 12 12 12 9.6 9.6 9.5 8.4 8.6 8.3 15 14 12 14 14 16 13 12 8.7 12 10 8.6 9.7 23 13 17 12 25 12 12 11 7.1 11 13 14
2.1 2.2 2.1 1.3 2.0 5.7 5.5 5.2 4.8 5.1 5.1 5.1 4.8 5.6 5.5 7.8 5.5 5.5 6.5 7.3 12 9.6 9.0 5.9 7.7 8.0 6.0 9.0 12 8.6 15 11 12 9.7 11 10 6.7 10 12 14
1.6 1.7 1.0 – 0.2 3.2 2.9 – 2.6 4.1 – – – 0.5 0.5 0.5 0.5 0.4 0.5 0.4 0.4 0.3 0.3 0.5 0.5 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.5 0.5 0.3 0.3 – 0.2 0.1 0.1
0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.4 0.2 0.3 0.2 0.2 0.6 0.6 0.7 0.4 0.3 0.4 0.3 0.4 0.0 0.4 0.4 0.2 0.2 0.4 0.4 0.1 0.3 0.4 0.7 0.6 1.1 1.2 1.7 0.5 0.9 0.8 2.2
– 0.0 0.0 0.0 5.7 0.0 0.0 0.0 3.3 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
23 23 24 25 26 27 29 31 32 32 34 36 38 39 41 47 156 158 161 165 166 168 173 178 178 180 165 169 170 172 177 181 182 185 190 124 125 127 134 139
11 12 12 13 14 14 17 18 18 18 19 21 22 23 24 26 27 29 31 33 32 34 37 40 40 40 27 26 25 26 29 31 30 31 34 -34 -34 -34 -29 -26
17 17 17 18 17 18 18 18 17 18 18 18 18 18 18 18 19 21 21 21 21 21 21 21 21 21 21 20 20 20 20 20 20 20 20 20 20 20 20 20

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?